RNASEH2B
protein-codingribonuclease H2 subunit B
Gene summary
RNase H2 is composed of a single catalytic subunit (A) and two non-catalytic subunits (B and C) and specifically degrades the RNA of RNA:DNA hybrids. The protein encoded by this gene is the non-catalytic B subunit of RNase H2, which is thought to play a role in DNA replication. Multiple transcript variants encoding different isoforms have been found for this gene. Defects in this gene are a cause of Aicardi-Goutieres syndrome type 2 (AGS2). [provided by RefSeq, Nov 2008]
- DLEU8
- AGS2
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~114.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0008315
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0012429
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0012429
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0700257
Submitter: ClinGen
RNASEH2B-related Type 1 Interferonopathy, Autosomal Recessive RNASEH2B was first reported in relation to autosomal recessive Aicardi-Goutieres syndrome type 2 (OMIM: 610326) in 2006 (PMID: 16845400). RNASEH2B encodes the ribonuclease H2 subunit B, which comprises 308 amino acids. RNASEH enzymes endolytically cleave ribonucleotides from RNA:DNA duplexes, which occur during DNA replication, transcription and translation. RNASEH2 has been proposed to function in the removal of lagging strand Okazaki fragment RNA primers during DNA replication, as well as in the excision of single ribonucleotides from RNA:DNA duplexes (PMIDs: 21177854, 16845400). The described autosomal recessive RNASEH2B phenotype is considered to be a form of type 1 interferonopathy, which is defined as a condition in which increased type 1 interferon signaling leads to autoimmune and neurological disorders (MONDO: 0700257). These disorders are caused by variants in genes involved in nucleic acid metabolism, sensing, and the innate immune response. Individuals with biallelic variants in RNASEH2B can present with a range of symptoms of variable severity and age of onset, within the context of an autoimmune disease. At least 10 unique variants (missense, splicing, nonsense) have been reported across 13 probands in 6 publications (PMIDs: 33981319, 33307271, 36775013, 22882256, 39183359, 25604658) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. The mechanism of pathogenicity is thought to be loss of function. This gene-disease relationship is also supported by experimental evidence (model system studies, PMIDs: 34655526, 26903602). A study by Aditi et al., 2021 generated a murine model of neural Rnaseh2b inactivation (Rnaseh2bNes-cre), which demonstrated cerebellar atrophy, loss of granule neurons and interneurons, thinning of the corpus callosum, loss of oligodendrocytes, and white matter abnormalities. A study by Mackenzie et al., 2016 generated a murine model by knock-in of the A174T missense variant (c.520A>G) into exon 7 of Rnaseh2b in mouse embryonic stem cells, which demonstrated reduced cellular levels of all three RNase H2 subunits and demonstrated significant interferon-stimulated gene (ISG) transcript upregulation that recapitulated the ISG signature observed in RNase H2 AGS patients. In summary, there is definitive evidence supporting the relationship between RNASEH2B and autosomal recessive RNASEH2B-related type 1 interferonopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic setting, and has been upheld over time. This classification was approved by the ClinGen Leukodystrophy and Leukoencephalopathy GCEP on the meeting date November 20, 2024 (SOP Version 11).
Inheritance Pattern: AD
Disease ID:MONDO:0018866
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0012429
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0012429
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Gastrointestinal; Dermatologic; Hematologic; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to RNASEH2B variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_024570.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 106 | 1 | 110 | ||
| missense | 10 | 149 | 7 | 166 | ||
| nonsense | 13 | 4 | 1 | 18 | ||
| start loss | 1 | 2 | 3 | |||
| frameshift | 16 | 6 | 10 | 1 | 33 | |
| splice donor/acceptor (+/-2bp) | 2 | 17 | 8 | 27 | ||
| Total | 32 | 39 | 171 | 114 | 1 | 357 |
Highest pathogenic variant AF is 0.002016424
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_078846.2 | 11 | MANE Select | |
| Ensembl | ENSP00000337623.2 | 11 | MANE Select | |
| RefSeq | NP_001135751.1 | 10 | Standard | |
| RefSeq | NP_001397952.1 | 11 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- DNA replication - Homo sapiens (human)
Biological Process
- in utero embryonic development
- RNA catabolic process
- ribonucleotide metabolic process
- regulation of G2/M transition of mitotic cell cycle
- negative regulation of gene expression
Molecular Function
- RNA-DNA hybrid ribonuclease activity
Cellular Component
- nucleus
- nucleoplasm
- ribonuclease H2 complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000336617
- Coding exons
- 11
- Length
- 60779
- Individuals with no LoFs
- 125708
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 40
- Defined
- 125748
- p
- 0.000159
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.239 | 154 | 146 | 1.06 | 0.00000666 | 2039 |
| Missense (PolyPhen) | 46 | 43.356 | 1.061 | 644 | ||
| Synonymous | -0.228 | 53 | 50.9 | 1.04 | 0.00000231 | 545 |
| Loss of Function | 0.760 | 15 | 18.5 | 0.810 | 7.76e-7 | 266 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00031 | 0.00031 | rare |
| Latino/Admixed American | 0.00017 | 0.00017 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00022 | 0.00020 | rare |
| South Asian | 0.00013 | 0.00013 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Non catalytic subunit of RNase H2, an endonuclease that specifically degrades the RNA of RNA:DNA hybrids. Participates in DNA replication, possibly by mediating the removal of lagging- strand Okazaki fragment RNA primers during DNA replication. Mediates the excision of single ribonucleotides from DNA:RNA duplexes. {ECO:0000269|PubMed:16845400, ECO:0000269|PubMed:21177858}.;
Intolerance Scores
- LoFtool
- 0.193
- RVIS EVS
- 0.04
- RVIS percentile EVS
- 56.92
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- N
- Indispensability score
- 0.275
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |